Sharmila Dissanaike - Jan 19, 2024 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Sharmila Dissanaike
Stock symbol
HRTX
Transactions as of
Jan 19, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 09:02 PM
Previous filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +13.9K +25.23% $0.00 69.2K Jan 19, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $0 +83.7K $0.00 83.7K Jan 19, 2024 Common Stock 83.7K $2.09 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 19, 2025.
F2 The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.